-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

703.P1.98 703. Cellular Immunotherapies: Basic and Translational: Poster I

Symposia: Cellular Immunotherapies: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Miranda H. Meeuwsen1*, Anne K. Wouters1*, Tassilo L.A. Wachsmann1*, Renate S. Hagedoorn1*, Michel G.D. Kester1*, Dennis F.G. Remst1*, Dirk M. van der Steen1*, Arnoud H. de Ru2*, Els P. van Hees1*, Marieke Griffioen1*, Peter A. van Veelen2*, J.H. Frederik Falkenburg1* and Mirjam H.M. Heemskerk1

1Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
2Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands

Marta Biondi, PhD1*, Stefania Galimberti, PhD2*, Beatrice Cerina1*, Chiara Tomasoni1*, Gianpietro Dotti, MD3*, Sarah Tettamanti, PhD1*, Andrea Biondi, MD1, Alice Pievani1* and Marta Serafini, PhD1*

1Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
2Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
3Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC

Xubin Li1*, Qing Deng, PhD2*, Jared Henderson, PhD2*, Grace Watson3*, Laurel Deaton4*, Taylor Cain1*, Luis Fayad, MD5, Swaminathan Padmanabhan Iyer, MD5*, Fredrick B. Hagemeister, MD6, Loretta J. Nastoupil, MD7, Nathan H. Fowler, MD5, Jason Westin, MD8, Raphael Steiner, MD5*, Ranjit Nair, MD9, Sairah Ahmed, MD8, Gheath Alatrash, PhD, DO10, Sattva S. Neelapu, MD11, Paolo Strati, MD5 and Michael R. Green, PhD12

1MD Anderson Cancer Center, Houston
2Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
31400 Holcombe Blvd, MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
8The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
10Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Pearland, TX
11Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
12Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Friendswood, TX

Cecile Pochon1,2*, Romain Perouf3*, Allan Bertrand4*, Anne-Béatrice Notarantonio5*, Naceur Charif6*, Marcelo De Carvalho Bittencourt, MD, PhD2*, Guillemette Fouquet, MD7*, Ghislaine Cauchois6*, Charlotte Voisin6*, Danièle Bensoussan8*, Patrick Emond9*, Hervé Sartelet, MD, PhD10*, David Moulin11*, Natalia de Isla6*, Maud d'Aveni12* and Marie Thérèse Rubio, MD, PhD2*

1Pediatric Onco-hematology Department, Children’s Hospital, University Hospital of Nancy, Vandoeuvre, France
2IMoPa, University of Lorraine, Vandoeuvre, France
3IMOPA laboratory, Team 6, UMR 7365 CNRS-UL, Université de Lorraine, VANDOEUVRE LES NANCY, France
4IMOPA laboratory, Team 6, UMR 7365 CNRS-UL, VANDOEUVRE LES NANCY, France
5Université De Lorraine, Nancy, FRA
6Team 6, UMR 7365 CNRS-UL, IMOPA, Université de Lorraine, VANDOEUVRE LES NANCY, France
7Institut Imagine, Inserm U1163, Paris, France
8Centre Hospitalier Universitaire De De Nancy, Vandoeuvre Les Nancy, FRA
9Université de Tours, TOURS, France
10Service d’anatomo-pathologie CHRU Nancy, Université de Lorraine, Vandoeuvre-lès-Nancy, France
11Université De Lorraine, CNRS, Vandœuvre Les Nancy, FRA
12CNRS UMR 7365 IMoPa, Biopôle de l’Université de Lorraine, Vandœuvre-lès-Nancy, France

Jaquelyn T. Zoine, PhD1, Sarah E. Moore, BS1, Kalyan Immadisetty, PhD2*, Shams Akel1*, Deanna M Langfitt, PhD1*, Jorge Ibanez-Vega, PhD1*, Lindsay Talbot, MD3*, Chris DeRenzo, MD1*, Giedre Krenciute, PhD1*, M. Madan Babu, PhD2* and Mireya Paulina Velasquez, MD1

1Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
2Department of Structural Biology and the Center for Data Driven Discovery, St. Jude Children's Research Hospital, Memphis, TN
3Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN

Hannah Lust, MD1, Stephen Miller, PhD2*, Reem Karmali, MD, MSc3 and Sonali Chaudhury, MD2,4*

1Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
2Northwestern University Feinberg School of Medicine, Chicago, IL
3Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL
4Ann and Robert Lurie Children's Hospital, Chicago, IL

Hongliang Qian1*, Florence Pik Hoon Gay1*, Jane Wan Lu Pang1*, Yunqin Lee1*, Joshur Ang1*, Hwee Ching Tan1*, Erica SH Lek1*, Dario Campana2 and Ying Xim Tan3

1MediSix Therapeutics, Singapore, Singapore
2Department of Pediatrics and Cancer Science Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
3Medisix Therapeutics, Singapore, Singapore

Jingjing Wen, M.D.1*, Jiajie Yang1*, Yanxin Chen, M.D. & Ph.D.1*, Ting Yang, MD, PhD1, Lingfeng Liu2* and Jianda Hu1

1Department of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
2School of Life Sciences, Fudan University, Shanghai, China, Shanghai, China

Yuta Kaito, MD1*, Emi Sugimoto2*, Fumi Nakamura3*, Yutaka Tsukune, MD, PhD4*, Makoto Sasaki, MD, PhD5*, Shunsuke Yui6*, Hiroki Yamaguchi, MD, PhD6, Susumu Goyama, MD PhD7*, Yasuhito Nannya, M.D., Ph.D.1, Kinuko Mitani, MD, PhD3, Hideto Tamura, MD, PhD8 and Yoichi Imai, MD, PhD3

1Department of Hematology/Oncology, IMSUT Hospital, The University of Tokyo, Tokyo, Japan
2Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, JPN
3Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
4Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
5Division of Hematology, Juntendo University School of Medicine, Tokyo, Japan
6Department of Hematology, Nippon Medical School, Tokyo, Japan
7Division of Molecular Oncology, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, TKY, Japan
8Department of Hematology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan

Maison Grefe1*, Abel Trujillo-Ocampo, PhD1, Drew Boagni, BSc1*, Jelita Clinton, MPH1*, Hong He, MD, PhD1*, Karen Clise-Dwyer, PhD2*, Hyunwoo Cho, PhD1*, Elizabeth J Shpall, MD3, Jeffrey J. Molldrem, MD4 and Jin S. Im, MD, PhD2,5

1Department of Hematopoietic Biology and Malignancies, The University of Texas MD Anderson Cancer Center, Houston, TX
2Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas,, Houston, TX

Mohammad Alhomoud, MD1, Jeremie Martinet1,2,3*, Mayumi Sugita, MD1, Takahiro Yamazaki, PhD4*, Olivier Boyer, MD, PhD2,3, Lorenzo Galluzzi, PhD4*, Silvia C Formenti, MD4*, Koen Van Besien, MD, PhD1 and Monica L. Guzman, PhD1

1Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
2University of Rouen Normandy, Inserm, U1234, F-76000, Rouen, France
3Rouen university hospital, Department of immunology and biotherapy, F-76000, Rouen, France
4Department of Radiation Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY

Juan Carlos Varela, MD, PhD1, Sojung Kim, PhD2*, Robert D Knight, MD3*, Emily Lu, PhD2*, Ruipeng Wang4* and Monzr M. Al Malki, MD5

1Dana Farber/Harvard Cancer Center, Beth Israel Deaconess Medical Center, Boston
2Neximmune Inc, Gaithersburg, MD
3Neximmune, Inc, Berkeley Heights, NJ
4Neximmune Inc, Gaithersberg, MD
5City of Hope, Duarte, CA

Darina Ocadlikova, PhD1*, Letizia Vitali2*, Michele Cavo, MD3* and Antonio Curti, MD, PhD4

1Department of Specialized, Diagnostic and Experimental Medicine, University of Bologna, Institute of Hematology “Seràgnoli”, Bologna, Italy
2Department of Oncology, University of Turin, Regione Gonzole 10, 10043 Orbassano, Orbassano, Italy
3Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy

Darin Salloum, PhD1*, Kavita Tundwal1*, Divy Kangeyan, PhD1*, Adam Johnson, PhD1*, Neal van Hoeven, PhD1*, Brian Granger1*, Jesus Moreno2*, Ouwen Liang1*, Pascal Beauchesne3*, Terry J. Fry, MD1 and Aaron Foster1

1Sana Biotechnology, Seattle, WA
2Sana Biotechnology, Seattle
3Sana Biotechnology, South San Francisco

Jeremy A. Meier, MD, PhD1,2, Katie E. Hurst, MPH1,3*, David L. Corcoran, PhD1,4*, Jessica E. Thaxton, PhD1,3* and Jonathan S. Serody, MD2,5,6

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Department of Medicine, Division of Hematology, University of North Carolina, Chapel Hill, NC
3Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC
4Department of Genetics, University of North Carolina, Chapel Hill, NC
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
6Department of Microbiology & Immunology, University of North Carolina, Chapel Hill, NC

Machiko Kusuda, MD1*, Hideki Nakasone, MD, PhD1, Akari Matsuoka, MD1*, Takuto Ishikawa, MD1*, Tomohiro Meno, MD1*, Yuhei Nakamura, MD1*, Masakatsu Kawamura, MD1*, Junko Takeshita, MD1*, Nozomu Yoshino, MD1*, Shunto Kawamura, MD1*, Kazuki Yoshimura, MD1*, Yukiko Misaki, MD1*, Ayumi Gomyo, MD1*, Masaharu Tamaki, MD1*, Kazuaki Kameda, MD1*, Shun-ichi Kimura, MD, PhD1*, Shinichi Kako2 and Yoshinobu Kanda, MD, PhD1

1Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama City, Japan
2Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan

Nicola C Maciocia, MD, FRCPath, PhD*, Amy Burley, BSc, MSc*, Malika Hoekx, MSci*, Thaneswari Karpanasamy, BSc, MSc*, Lydia Lee*, David O'Connor, MBBS, PhD, FRCPath (Haem)*, Marc R. Mansour, MD*, Asim Khwaja, MD, FRCP, FRCPath*, Paul M Maciocia, PhD, BSc, FRCPath and Martin Pule, MD, PhD*

Cancer Institute, University College London, London, United Kingdom

Brian Garrison, PhD1*, Han Deng, PhD1*, Gozde Yucel, PhD1*, Nicholas W. Frankel, PhD1*, Russell Gordley, PhD1*, Michelle Hung, PhD1*, Derrick Lee1*, Marcus Gainer1*, Assen Roguev, PhD1*, Wesley Gorman1*, Nelia Leemans, MS1*, Alice Lam1*, Yongshuai Li, MS1*, Wilson Wong, PhD2*, Kanya L. Rajangam, MD, PhD1, Philip Lee, PhD1* and Tim Lu, MD PhD1*

1Senti Biosciences, South San Francisco, CA
2Department of Biomedical Engineering, Boston University, Boston, MA

Satoru Aoyama, M.D., Ph.D.1,2*, Ayako Nogami, M.D., Ph.D.1,3, Sadakatsu Ikeda, M.D., Ph.D.2* and Takehiko Mori, M.D., Ph.D.1*

1Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
2Department of Precision Cancer Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
3Department of Laboratory Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

Leling Xie*, Runxia Gu*, Xue Yang, MD*, Shaowei Qiu, MD*, Yingxi Xu*, Junli Mou*, Ying Wang, MD, Haiyan Xing, MS*, Kejing Tang, BS*, Zheng Tian*, Qing Rao, MS*, Min Wang* and Jianxiang Wang*

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Carli M. Stewart, BS1,2,3,4, Michelle J. Cox, Ph.D.1,3, Reona Leo Sakemura, MD, PhD1,3, Ekene J. Ogbodo, Ph.D.1,3*, Ismail Can, PhD1,3,4,5, Claudia Manriquez-Roman1,3,4,6, Kun Yun1,3,4,6, Olivia Sirpilla, BS1,2,3,4, James H. Girsch1,3,4,6*, Truc Huynh1,3*, Elizabeth L. Siegler, Ph.D.1,3*, Jenny J Kim, MD, MS7, Mike Mattie, PhD7*, Nathalie Scholler, MD PhD7*, Simone Filosto, PhD7* and Saad S. Kenderian, MD1,3,6,8

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN
3T Cell Engineering, Mayo Clinic, Rochester, MN
4Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN
5Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN
6Department of Molecular Medicine, Mayo Clinic, Rochester, MN
7Department of Oncology, Gilead Sciences Inc., Foster City, CA
8Department of Immunology, Mayo Clinic, Rochester, MN

Jeong-A Kim1, Jinhang KIM2*, Saetbyeol Kim2*, Misuk Yang2*, Youngrok Park3* and Jae-Yong Kwak, MD, PhD4

1Department of Hematology, St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea
2Department of Hematology, St. Vincent Hospital, The Catholic University of Korea, Suwon, Korea, Republic of (South)
3Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington D.C., DC
4Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea, Republic of (South)

Lee Swanson, PhD1*, Kenyon Lyon1*, Wael Tadros, PhD1*, Mafalda Loreti, PhD1*, Tammy Babin1*, Benjamin Blair1*, Max Schabla, PhD1*, Paschalis Sideras, PhD1*, Dan S Kaufman, MD, PhD2, Robert Hollingsworth, PhD1* and Huang Zhu1*

1Shoreline Bioscience, San Diego
2Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA

Rolando A. Vedia, MS*, Sijie Lu, PhD*, Anne Philip, PhD*, Anna Sergeeva, PhD*, Lisa St John, PhD*, Karen Clise-Dwyer, PhD* and Jeffrey J. Molldrem, MD

Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX

Nadine E. Struckman1*, Sebastian Klobuch, MD1*, Michel G.D. Kester1*, Wendy de Klerk1*, Arnoud H. de Ru2*, Mirjam H.M. Heemskerk1, Peter A. van Veelen2*, Peter van Balen1, J.H.Frederik Falkenburg, MD, PhD1 and Marieke Griffioen1*

1Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
2Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands

Alan M Williams, PhD1*, Ken L Hayama, PhD1*, Yijia Pan, PhD1*, Brian Groff, BS1*, Rina M Mbofung, PhD1*, Amber Chang, PhD1*, Christine Chen2*, Lauren Fong, PhD1*, Nicholas Brookhouser, PhD1*, Berhan Mandefro1*, Ramzey Abujarour, PhD1*, Tom Lee, PhD1*, Maksim Mamonkin, PhD3, Raedun Clarke, PhD1*, Ryan Bjordahl2*, Jode P Goodridge4* and Bahram Valamehr4

1Fate Therapeutics Inc., San Diego, CA
2Fate Therapeutics, San Diego, CA
3Department of Pathology & Immunology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
4Fate Therapeutics, Inc., San Diego, CA

Kai Rejeski, MD1, Ariel Perez Perez, MD2,3, Gloria Iacoboni, MD4*, Veit L Buecklein, MD1*, Viktoria Blumenberg, MD1, Simon Voelkl, PhD5*, Olaf Penack, MD6*, Omar Albanyan, MD3, Simon KG Forsberg, PhD7*, Agnese Petrera, PhD8*, Niklas Mueller, MD, PhD1*, Kayla M. Reid, M.S.3*, Rawan Faramand, MD3, Marco L. Davila, MD, PhD3, Michael von Bergwelt, Prof. Dr.1*, Frederick L. Locke, MD3, Wolfgang Bethge, MD9*, Lars Bullinger, MD6, Andreas Mackensen, MD10*, Pere Barba, MD, PhD4*, Michael D. Jain, MD, PhD11 and Marion Subklewe, MD12

1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health, Miami, FL
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
5Department of Internal Medicine 5, University of Erlangen-Nuremberg, Erlangen, Germany
6Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany
7Data Science Team, Olink Proteomics, Uppsala, Sweden
8Metabolomics and Proteomics Core Facility, Helmholtz Zentrum Munich – German Research Center for Environmental Health, Munich, Germany
9Hematology & Oncology, Universitaet Tuebingen, Medizinische Klinik, Tuebingen, Germany
10Department of Internal Medicine 5 - Hematology/Oncology, University Hospital of Erlangen, Erlangen, Germany
11Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
12Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Adam Johnson, PhD1*, Hallee Wright1*, Xiaomeng Hu, PhD2*, Neal van Hoeven, PhD1*, Brian Granger1*, Ouwen Liang1*, Jesus Moreno3*, Meghan Lamba2*, Chi Young2*, Andrew McAlister1*, Terry J. Fry, MD1, Sonja Schrepfer4* and Aaron Foster1

1Sana Biotechnology, Seattle, WA
2Sana Biotechnology, San Francisco, CA
3Sana Biotechnology, Seattle
4Sana Biotechnology Inc, San Mateo, CA

Sisi Wang1*, Alberto J Arribas2*, Chiara Tarantelli2*, Amandine Pradier3*, Lodovico Terzi Di Bergamo4*, Emanuele Zucca, MD2,5*, Davide Rossi, MD, PhD2,5, Federico Simonetta, MD, PhD3* and Francesco Bertoni, MD2,5

1Division of Hematology, Department of Oncology, and Translational Research Centre in Onco-Haematology, Geneva University Hospitals, University of Geneva, Genève, Switzerland
2Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland
3Division of Hematology, Department of Oncology, and Translational Research Centre in Onco-Haematology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland
4Institute of Oncology Research,Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland
5Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Yuhang Cheng1*, Jiayuan Zhang2*, Xiaoqian Wang2*, Wenjie Dong2*, Xiaomin Yao2*, Yage Zhang2*, Juan Yang2*, Wei Mu3*, Jue Wang, M.D., Ph.D.4*, Liang Huang, MD5,6 and Guang Hu, PhD3*

1Tongji Hospital, Tongji Medical College,Huazhong University of Science and Techn, Wuhan, China
2Shanghai IASO Biotherapeutics, Shang Hai, China
3IASO Biotherapeutics, Nanjing, China
4Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China
6Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Nawid Albinger1*, Tobias Bexte1*, Leon Buchinger1*, Philipp Wendel1*, Ahmad Al-Ajami2*, Alec Gessner3,4,5*, Vinzenz Särchen6*, Jamal Alzubi7*, Sarah Mertlitz8*, Olaf Penack, MD9,10*, Raj Bhayadia, PhD11*, Jan-Henning Klusmann, MD11, Meike Vogler6*, Nina Möker12*, Toni Cathomen, PhD7*, Michael A Rieger3,5,13*, Katharina Imkeller3,14,15* and Evelyn Ullrich, MD1,3,5,15

1Experimental Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany
2Goethe University, Frankfurt, Germany
3Frankfurt Cancer Institute (FCI), Frankfurt, Germany
4Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe-University, Frankfurt, Germany
5German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Frankfurt, Germany
6Goethe University Frankfurt, Frankfurt, Germany
7Medical Center, Institute for Transfusion Medicine & Gene Therapy, University of Freiburg, Freiburg, Germany
8Charite University Medicine, Campus Virchow Clinic, Berlin, Germany
9Department of Hematology, Oncology and Tumorimmunology, Charité University Hospital, Campus Virchow Clinic, Berlin, Germany
10Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany
11Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany
12Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany
13Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany
14Edinger Institute (Neurological Institute), University Hospital Frankfurt, Frankfurt, Germany
15University Cancer Center (UCT), Frankfurt, Germany

John Reiser1*, Szeman Ruby Chan2*, Ketan Mathavan1*, David Sillitti2*, Cristina Mottershead2*, Bethany Mattson2*, Melissandre Pache1*, Alma Gutierrez1*, Whitney Scoon1*, Yanni Zhu1*, Andrew Gilder1*, Christine Chen1*, Kimberly Staquet2*, Michael Ports2*, Charles Drake2*, Joseph Erhardt2*, Ryan Bjordahl1*, Jode P Goodridge3* and Bahram Valamehr3

1Fate Therapeutics, San Diego, CA
2The Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA
3Fate Therapeutics, Inc., San Diego, CA

*signifies non-member of ASH